Employees: 21 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2004-07-16 (21 years)Status: ActiveBusiness sector: Edition de logiciels applicatifsLocation: COURBEVOIE (92400), Hauts-de-Seine
KASPERSKY LAB FRANCE : revenue, balance sheet and financial ratios
KASPERSKY LAB FRANCE is a French company
founded 21 years ago,
specialized in the sector Edition de logiciels applicatifs.
Based in COURBEVOIE (92400),
this company of category PME
shows in 2024 a revenue of 22.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - KASPERSKY LAB FRANCE (SIREN 478315872)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
22 400 142 €
22 016 295 €
22 549 209 €
29 947 191 €
26 388 413 €
25 095 449 €
19 196 348 €
13 513 696 €
13 110 159 €
Net income
733 109 €
1 328 333 €
1 452 850 €
1 178 257 €
1 564 346 €
998 359 €
679 674 €
898 358 €
1 091 102 €
EBITDA
801 199 €
1 933 562 €
2 767 000 €
1 755 854 €
2 364 203 €
2 277 436 €
1 099 566 €
1 348 073 €
1 294 309 €
Net margin
3.3%
6.0%
6.4%
3.9%
5.9%
4.0%
3.5%
6.6%
8.3%
Revenue and income statement
In 2024, KASPERSKY LAB FRANCE achieves revenue of 22.4 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +6.9%. Vs 2023: +2%. After deducting consumption (8 k€), gross margin stands at 22.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 801 k€, representing 3.6% of revenue. Warning negative scissor effect: despite revenue change (+2%), EBITDA varies by -59%, reducing margin by 5.2 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 733 k€, i.e. 3.3% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
22 400 142 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
22 392 321 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
801 199 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
769 439 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
733 109 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
3.6%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
21.816%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
25.843%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
3.2%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
1.307
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution KASPERSKY LAB FRANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
0.0
0.0
0.0
0.0
0.305
103.823
86.263
63.911
21.816
Financial autonomy
64.717
62.758
15.362
12.343
19.783
18.889
12.489
17.207
25.843
Repayment capacity
0.0
0.0
0.0
0.0
0.009
5.625
1.115
1.99
1.307
Cash flow / Revenue
8.001%
8.015%
3.366%
5.662%
5.797%
3.649%
7.659%
5.196%
3.2%
Sector positioning
Debt ratio
21.822024
2022
2023
2024
Q1: 0.0
Med: 5.29
Q3: 44.39
Average-14 pts over 3 years
In 2024, the debt ratio of KASPERSKY LAB FRANCE (21.82) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
25.84%2024
2022
2023
2024
Q1: 11.65%
Med: 39.77%
Q3: 62.21%
Average+13 pts over 3 years
In 2024, the financial autonomy of KASPERSKY LAB FRANCE (25.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
1.31 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.8 years
Average
In 2024, the repayment capacity of KASPERSKY LAB FRANCE (1.31) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 142.69. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 14.5x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
142.691
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
14.548
Liquidity indicators evolution KASPERSKY LAB FRANCE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
35.67
30.012
73.422
72.804
111.504
161.209
128.661
135.961
142.691
Interest coverage
0.043
0.044
0.406
0.655
1.832
0.094
0.608
5.139
14.548
Sector positioning
Liquidity ratio
142.692024
2022
2023
2024
Q1: 146.39
Med: 243.79
Q3: 459.15
Watch
In 2024, the liquidity ratio of KASPERSKY LAB FRANCE (142.69) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
14.55x2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 2.19x
Excellent+17 pts over 3 years
In 2024, the interest coverage of KASPERSKY LAB FRANCE (14.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 143 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 169 days. Favorable situation: supplier credit is longer than customer credit by 26 days. Overall, WCR represents 165 days of revenue, i.e. 10.3 M€ to permanently finance. Over 2016-2024, WCR increased by +677%, requiring additional financing.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
10 272 705 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
143 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
169 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
165 j
WCR and payment terms evolution KASPERSKY LAB FRANCE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
-1 780 097 €
-1 946 242 €
3 630 797 €
8 339 720 €
568 934 €
10 414 735 €
6 728 007 €
15 537 120 €
10 272 705 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
104
133
101
119
84
175
143
Supplier payment term (days)
76
153
225
323
124
110
114
311
169
Positioning of KASPERSKY LAB FRANCE in its sector
Comparison with sector Edition de logiciels applicatifs
Valuation estimate
Based on 103 transactions of similar company sales
(all years),
the value of KASPERSKY LAB FRANCE is estimated at
2 239 195 €
(range 932 705€ - 5 527 518€).
With an EBITDA of 801 199€, the sector multiple of 1.0x is applied.
The price/revenue ratio is 0.25x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
103 transactions
932k€2239k€5527k€
2 239 195 €Range: 932 705€ - 5 527 518€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
801 199 €×1.0x
Estimation777 639 €
255 019€ - 2 512 909€
Revenue Multiple30%
22 400 142 €×0.25x
Estimation5 573 872 €
2 462 293€ - 12 267 129€
Net Income Multiple20%
733 109 €×1.2x
Estimation891 072 €
332 539€ - 2 954 627€
How is this estimate calculated?
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Edition de logiciels applicatifs)
Compare KASPERSKY LAB FRANCE with other companies in the same sector:
Frequently asked questions about KASPERSKY LAB FRANCE
What is the revenue of KASPERSKY LAB FRANCE ?
The revenue of KASPERSKY LAB FRANCE in 2024 is 22.4 M€.
Is KASPERSKY LAB FRANCE profitable?
Yes, KASPERSKY LAB FRANCE generated a net profit of 733 k€ in 2024.
Where is the headquarters of KASPERSKY LAB FRANCE ?
The headquarters of KASPERSKY LAB FRANCE is located in COURBEVOIE (92400), in the department Hauts-de-Seine.
Where to find the tax return of KASPERSKY LAB FRANCE ?
The tax return of KASPERSKY LAB FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does KASPERSKY LAB FRANCE operate?
KASPERSKY LAB FRANCE operates in the sector Edition de logiciels applicatifs (NAF code 58.29C). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart